공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

심혈관 초음파 시스템 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Cardiovascular Ultrasound System Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 707339
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


심혈관 초음파 시스템 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Cardiovascular Ultrasound System Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 심혈관 초음파 시스템(Cardiovascular Ultrasound System) 시장을 조사했으며, 시장 개요, 검사 종류·기술·디바이스 디스플레이·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 영향요인

제5장 시장 개요

  • 현재의 시장 시나리오
  • Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 진출기업의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제6장 성장 촉진요인 및 저해요인, 시장 기회, 과제(DROC)

  • 시장 성장 촉진요인
    • 심장혈관 질환(CVD) 이환율 상승
    • 기술적 진보
    • 침습적 시술과 비교했을 때 심장 초음파 검사의 장점
  • 시장 성장 저해요인
    • 불리한 상환 시나리오
    • 신기술 도입의 경제적 영향
  • 시장 기회
  • 주요 과제

제7장 심혈관 초음파 시스템 시장 : 부문별

  • 검사 종류별
    • 경흉강 심장 초음파 검사
    • 경식도 심장 초음파 검사
    • 운동부하 심장 초음파 검사
    • 기타
  • 기술별
    • 2D
    • 3D, 4D
    • 도플러 이미징
  • 디바이스 디스플레이별
    • 컬러 디스플레이
    • 흑백 디스플레이
  • 최종사용자별
    • 병원, 심장병 센터
    • 외래치료, 재택치료
    • 의료기기 제조업체와 제약기업
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제8장 기업 개요와 경쟁 구도

  • Canon Medical Systems
  • Chison
  • Esaote SpA
  • GE Healthcare
  • Canon Medical Systems
  • KPI Healthcare Inc.
  • Philips Healthcare
  • Siemens Healthcare
  • Samsung Electronics Co., Ltd
  • Whale Imaging

제9장 시장 전망

LSH 18.10.19

The global cardiovascular ultrasound systems market was expected to register a CAGR of 5.9% over the forecast period.

The COVID-19 has a profound impact on the cardiovascular imaging system in 2020. The factor negatively impacting the studied market is the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

However, patients with underlying heart disease are at higher risk of severe illness for COVID-19. In Such Patients, diagnostic ultrasound can and is being used to diagnose COVID-19 in patients. Ultrasound of the heart, which can be performed at the bedside, has become a key tool for clinicians while treating and monitoring COVID-19 patients. The risk of contamination and nosocomial spreading associated with the usage of the standard diagnostic tools such as stethoscope and radiology imaging systems in the management of COVID -19, has contributed to the rising demand of pocket-sized cardiovascular ultrasound systems changing the dynamics of these market space.

The major factors for the growth of the cardiovascular ultrasound system market include - the increasing incidence of cardiovascular diseases (CVDs), rise in technological advancements, and advantages of echocardiography over invasive cardiac diagnostic procedures.

Cardiovascular diseases (CVD) remain a substantial cause of morbidity and mortality in the developed world and are becoming an increasingly important cause of death in developing countries as well. As per the 2020 updates of World Health Organization, ischemic heart disease, responsible for 16% of the world's total deaths. Since 2000, the largest increase in deaths has been for ischemic heart disease, rising by more than 2 million to 8.9 million deaths in 2019. Consequently, the increase in the number of cardiovascular diseases has increased the demand for cardiovascular ultrasound system for the diagnosis.

Technological advancement such as artificial intelligence is having a significant positive impact on cardiology with improved capabilities to diagnose certain heart conditions. For instance, in October 2020, GE Healthcare received the US FDA 510k clearance for its ultra edition package of vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.

However, factors such as unfavorable reimbursement scenario and economic impact of adopting new technologies is impeding the studied market growth over upcoming period.

Key Market Trends

2D Ultrasound Imaging Segment is Expected to be Fastest Growing Segment Over the Forecast Period

The COVID-19 has impacted the production of 2D cardiovascular ultrasound systems in 2020. Furthermore, the delay of elective procedures, due to COVID-19-related measures, has adversely affected the cardiovascular medical devices market especially in the year 2020. While some cardiovascular procedures are considered urgent, others have been postponed and delayed since the beginning of the global pandemic. Hence, lifestyle changes and medication can be temporarily prescribed instead of cardiovascular procedures for some patients. Another factor negatively impacting the verticle is the reduction in the diagnosis of cardiovascular diseases due to healthcare resources being reserved for COVID-19 patients.

2D ultrasound imaging is also known as B-mode echography or sonography. It displays a 2D map of B-mode data and is currently the most common form of cardiac ultrasound imaging used, worldwide. It uses multiple transducers. It enables the generation of multiple images of the field or frames every second on the screen, giving an illusion of movement. It is primarily used to measure cardiac chamber dimensions, assess valvular structure and function, and improve the accuracy of interpretation of Doppler modalities.

2D ultrasound is one of the most common forms of technology used. However, it has disadvantages, like low resolution, distortion of ultrasound wave resulting in inaccurate images, view of the internal bone structure, and regional placement.

Moreover, technological advancements, like Doppler imaging and 3D/4D ultrasound imaging, are expected to affect the global 2D imaging market during the forecast period.For instance, in October 2020, Royal Philips launched the Ultrasound 3300, a new innovative ultrasound series tailored for general Imaging and cardiovascular Imaging procedures. Such product advancement will boost the vertical growth over upcoming years.

North America is Expected to Dominate the Market Over the Forecast Period and Expected to Do the Same

North America is anticipated to lead the market owing to the high adoption of ultrasound modality in general diagnostics and the rising prevalence of lifestyle-associated chronic diseases. Also, the high demand for technologically advanced medical devices is expected to propel market growth in the region.

According to the American Heart Association Research Report 2018, Heart disease accounts for 1 in 7 deaths in the United States. Coronary Heart Disease is the leading cause (43.8%) of deaths attributable to cardiovascular disease in the United States, followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), diseases of the arteries (3.1%), and other cardiovascular diseases (17.9%). This scenario is leading to a higher demand of cardiovascular ultrasound systems for better diagnosis which will be driving the market in the United States.

Furthermore, supportive awareness initiatives for disease awareness are projected to support the market for cardiovascular devices in the North American region. For instance, In 2020, Mexico has joined the HEARTS initiative to strengthen primary health care for CVD. Promoted by the Pan American Health Organization/ World Health Organization (PAHO/WHO), the initiative aims to improve the prevention and control of hypertension at the primary care level.

Competitive Landscape

The market studied is moderately consolidated, owing to the presence of many small and large market players. Some of the market players are Canon Medical Systems, Chison, Esaote SpA, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips NV, KPI Healthcare Inc., Samsung Healthcare, Siemens Healthcare, and Whale Imaging. Regional and service portfolio expansions and mergers and acquisitions are key strategic undertakings adopted by these players.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidence of Cardiovascular Diseases (CVDs)
    • 4.2.2 Rise in Technological Advancements
    • 4.2.3 Advantages of Echocardiography over Invasive Cardiac Diagnostic Procedures
  • 4.3 Market Restraints
    • 4.3.1 Unfavorable Reimbursement Scenario
    • 4.3.2 Economic Impact of Adopting New Technologies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Test Type
    • 5.1.1 Transthoracic Echocardiogram
    • 5.1.2 Transesophageal Echocardiogram
    • 5.1.3 Stress Echocardiogram
    • 5.1.4 Other Test Types
  • 5.2 By Technology
    • 5.2.1 2D
    • 5.2.2 3D and 4D
    • 5.2.3 Doppler Imaging
  • 5.3 By Device Display
    • 5.3.1 Color Display
    • 5.3.2 Black and White (B/W) Display
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Centers
    • 5.4.3 Other End Users
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Canon Medical Systems
    • 6.1.2 Chison
    • 6.1.3 Clarius Mobile Health
    • 6.1.4 Esaote SpA
    • 6.1.5 GE Healthcare
    • 6.1.6 Hitachi Medical Corporation
    • 6.1.7 Kalamed Medical System
    • 6.1.8 Koninklijke Philips NV
    • 6.1.9 KPI Healthcare Inc.
    • 6.1.10 Medisono Llc
    • 6.1.11 Samsung Healthcare
    • 6.1.12 Shenzhen Biocare Bio-Medical Equipment Co., Ltd.
    • 6.1.13 Siemens Healthcare GmbH
    • 6.1.14 Whale Imaging

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q